InsiderTrades

Form 4 for EQH Equitable Holdings, Inc.

Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0000950170-24-016509 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2024-02-16 2024-02-15 EQH Lane Nick (See Remarks) M - OptEx $23.18 +10.0K 186.1K +6% +$231.8K
DT 2024-02-16 2024-02-14 EQH Lane Nick (See Remarks) A - Grant $0.00 +32.0K 176.1K +22% $0
DMT 2024-02-16 2024-02-15 EQH Lane Nick (See Remarks) S - Sale+OE $34.27 -20.0K 166.1K -11% -$685.4K
DT 2024-02-16 2024-02-15 EQH Lane Nick (See Remarks) M - OptEx $0.00 -10.0K 84.4K -11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-15 M A 10,000 $23.18 186,095.41 D — — (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023. (F2) Total includes Restricted Stock Units.
2 Common Common Stock 2024-02-14 A A 31,963 $0.00 176,095.41 D — — (F1) Grant of restricted stock units under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three ratable annual installments beginning on February 28, 2025. Vested shares will be delivered to the reporting person within 30 days following the vesting date. (F2) Total includes Restricted Stock Units.
3 Common Common Stock 2024-02-15 S D 10,000 $34.27 176,095.41 D — — (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023. (F4) This transaction was executed in multiple trades at prices ranging from $34.0000 to $34.8000. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units.
4 Common Common Stock 2024-02-15 S D 10,000 $34.27 166,095.41 D — — (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023. (F4) This transaction was executed in multiple trades at prices ranging from $34.0000 to $34.8000. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units.
5 Derivative Employee Stock Option (right to buy) 2024-02-15 M D 10,000 $0.00 84,417 D $23.18 · — to 2030-02-26 10,000 Common Stock (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023. (F5) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vest/vested in three installments beginning on February 26, 2020